The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells
Abstract
Abstract Multiple growth factors can stimulate quiescent vascular smooth muscle cells to exit from G0 and reenter the cell cycle. The macrolide antibiotic rapamycin, bound to its cytosolic receptor FKBP, is an immunosuppressant and a potent inhibitor of cellular proliferation. In the present study, the antiproliferative effects of rapamycin on human and rat vascular smooth muscle cells were examined and compared with the effects of a related immunosuppressant, FK520. In vascular smooth muscle cells, rapamycin, at concentrations as low as 1 ng/mL, inhibited DNA synthesis and cell growth. FK520, an analogue of the immunosuppressant FK506, is structurally related to rapamycin and binds to FKBP but did not inhibit vascular smooth muscle cell growth. Molar excesses of FK520 blocked the antiproliferative effects of rapamycin, indicating that the effects of rapamycin required binding to FKBP. Rapamycin-FKBP inhibited retinoblastoma protein phosphorylation at the G1/S transition. This inhibition of retinoblastoma protein phosphorylation was associated with a decrease in p33 cdk2 kinase activity. These observations suggest that rapamycin, but not FK520, inhibits vascular smooth muscle cell proliferation by reducing cell-cycle kinase activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., & Roberts, J. M. (1992) · Science · doi:10.1126/science.1388288 · Cited by 1,043
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., & Nadal-Ginard, B. (1993) · Cell · doi:10.1016/0092-8674(93)90110-c · Cited by 729
Austin, G. E., Ratliff, N. B., Hollman, J., Tabei, S., & Phillips, D. F. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80174-1 · Cited by 574
Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.
Berk, B. C., Vekshtein, V, Gordon, H. M., & Tsuda, T. (1989) · Hypertension · doi:10.1161/01.hyp.13.4.305 · Cited by 556
Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins.
Hannon, G. J., Demetrick, D., & Beach, D. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2378 · Cited by 465
Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8474 · Cited by 458
Cell cycle dependent regulation of phosphorylation of the human retinoblastoma gene product
Mihara, K., Cao, X.-R., Yen, A., Chandler, S., Driscoll, B., Murphree, A. L., T'Ang, A., & Fung, Y.-K. (1989) · Science · doi:10.1126/science.2588006 · Cited by 449
Percutaneous Transluminal Coronary Angioplasty
Landau, C., Lange, R. A., & Hillis, L. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301407 · Cited by 445
Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a)
Grainger, D. J., Kirschenlohr, H. L., Metcalfe, J. C., Weissberg, P. L., Wade, D. P., & Lawn, R. M. (1993) · Science · doi:10.1126/science.8503012 · Cited by 408
Migration of smooth muscle and endothelial cells. Critical events in restenosis.
Casscells, W. (1992) · Circulation · doi:10.1161/01.cir.86.3.723 · Cited by 399
Angiotensin II Induces c-fos mRNA in Aortic Smooth Muscle
Taubman, M. B., Berk, B. C., Izumo, S., Tsuda, T., Alexander, R. W., & Nadal-Ginard, B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31290-5 · Cited by 396
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.
Lees, J. A., Buchkovich, K. J., Marshak, D. R., Anderson, C. W., & Harlow, E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb05006.x · Cited by 337
Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.
Pagano, M., Pepperkok, R., Lukas, J., Baldin, V, Ansorge, W., Bartek, J., & Draetta, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.101 · Cited by 322
Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.
Hosenpud, J. D., Shipley, G. D., & Wagner, C. R. (1992) · PubMed · Cited by 218
Gorski, D. H., LePage, D. F., Patel, C. V., Copeland, N. G., Jenkins, N. A., & Walsh, K. X. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3722 · Cited by 151
The Retinoblastoma Protein Physically Associates with the Human cdc2 Kinase
Hu, Q., Lees, J. A., Buchkovich, K. J., & Harlow, E. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.971 · Cited by 109
Jayaraman, T., & Marks, A. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74403-2 · Cited by 101
Self-citationIntegration of cell cycle control with transcriptional regulation by the retinoblastoma protein
Hollingsworth, R. E., Chen, P., & Lee, W. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90102-v · Cited by 79
Reddy, K. B., & Howe, P. H. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560108 · Cited by 60
Smooth muscle cell and endothelial cell growth factors
Klagsbrun, M., & Dluz, S. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90042-5 · Cited by 31
Kiyokawa, H., Ngo, L., Kurosaki, T., Rifkind, R. A., & Marks, P. A. (1992) · PubMed · Cited by 17
Molecular atherectomy for restenosis
Casscells, W., Lappi, D. A., & Baird, A. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90045-8 · Cited by 10
Cited by
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Lüscher, T. F., Steffel, J., Eberli, F. R., Joner, M., Nakazawa, G., Tanner, F. C., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.106.675934 · Cited by 906
Groth, C. G., Bäckman, L., Morales, J.-M., Calne, R., Kreis, H., Lang, P., Touraine, J.-L., Claesson, K., Campistol, J. M., Durand, D., et al. (1999) · Transplantation · doi:10.1097/00007890-199904150-00017 · Cited by 878
Coronary stents: A materials perspective
Mani, G., Feldman, M. D., Patel, D., & Agrawal, C. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.042 · Cited by 866
Sousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mattos, L. A., Sousa, A. G. M. R., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.192 · Cited by 793
Metadata
- Authors
- Marx, S. O., Jayaraman, T., Go, L. O., & Marks, A. R.
- Venue
- Circulation Research
- Published
- 1995-03
- Volume
- 76
- Issue
- 3
- Pages
- 412-417
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2067196635
- Cited by
- 599
- References
- 26
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.